As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...
As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...
https://sitescdn.wearevennture.co.uk/public/barrington-james/assets/cardiology-cad295613a304a89907c1437c6ab4e95.webp
Discover how to align your commercial hiring with the demands of cutting-edge cardiology tec...
https://sitescdn.wearevennture.co.uk/public/barrington-james/assets/orthpedics-a254c61f9f7443ccb7ce5657f556beae.webp
Download our expert insight paper to uncover the commercial hiring mistakes stalling go-to-m...
We collaborated with a startup medical device company focused on MRI technology for stroke d...
In Q4 2024, we partnered with an orthopedic medical device startup in the joint reconstructi...
The ChallengeA small molecule CDMO faced over a 70% turnover rate, struggled to meet product...
A cardiovascular medical device company (a publicly traded company generating around $300 mi...
Learn how Barrington James successfully assembled a dedicated commercial team for a mid-size...